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Ephs and ephrins are a family of membrane-bound proteins
that function as receptor–ligand pairs. Members of the
Eph–ephrin-B family have recently been reported to regulate
the paracellular permeability of epithelial cells. In this study,
we analyzed the expression and the function of ephrin-B1 in
glomeruli. Using immunofluorescence (IF), we found that
ephrin-B1 was expressed along the glomerular capillary loop.
Immunoelectron microscopy revealed that ephrin-B1
expression was restricted at the slit diaphragm. Dual labeled
IF showed ephrin-B1 colocalized with the slit diaphragm
proteins nephrin and CD2-associated protein. Ephrin-B1
colocalized with nephrin at the late capillary loop stage of
kidney development. Additionally, injection of rats with
a nephritogenic anti-nephrin antibody (ANA) reduced
ephrin-B1 expression. When podocytes were cultured in vitro,
they extruded processes that co-stained for ephrin-B1 and
for CD2-associated protein. When these podocytes were
treated in culture with small interfering RNA for ephrin-B1,
CD2-associated protein was reduced in the processes,
with a remaining faint perinuclear staining. We suggest
that ephrin-B1 has a role in maintaining barrier function at
the slit diaphragm.
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The visceral glomerular epithelial cell (podocyte) is a highly
specialized terminally differentiated cell, characterized by
interdigitating foot processes and a slit diaphragm connect-
ing adjacent foot processes.1–3 Since the neighboring foot
processes are derived from different podocytes, the slit
diaphragm is a highly developed variant of the cell-to-cell
junction. Some studies have revealed that the slit diaphragm
functions as a final permeability barrier of the glomerular
capillary wall, and that the dysfunction of the slit diaphragm
is involved in the development of proteinuria in several
glomerular diseases such as minimal-change nephrotic
syndrome and membranous nephropathy.4,5 Another specia-
lized feature of the podocyte is its specific cytoskeletal
organization, which plays a role in counteracting the high
distending force permitting high-pressure perfusion and in
maintaining the architecture of the glomerulus.6,7 In the past
several years, some molecules such as nephrin, neph1, and
FAT have been identified as functional molecular constituents
of the extracellular site of the slit diaphragm.3,8–10 Nephrin
interacts with the actin cytoskeleton via the intracellular
adaptor proteins CD2-associated protein (CD2AP) and
podocin.3,11,12 Recently, it has been reported that nephrin
also binds to the PDZ (PSD-95/Discs Large/ZO-1) domain-
containing molecule CASK (calcium/calmodulin-dependent
serine protein kinase) for connecting with actin.13,14 Nephrin
has also drawn attention as a signal molecule,15–17 and it is
reported that phosphorylated nephrin interacts with fyn and
Nck adaptor proteins.18–20 However, the precise molecular
composition of the slit diaphragm and the molecular
organization, which enables the interaction of the slit
diaphragm with the actin filament, are not well understood
yet. Another important question, namely how the slit
diaphragm, which has such a sophisticated structure, is
formed and maintained, remains largely unanswered.
Ephs and ephrins are membrane-bound proteins that
function as receptor–ligand pairs.21–23 Sixteen Ephs and eight
ephrins have been identified in vertebrate so far. Ephs are
divided on the basis of sequence homology and ligand affinity
into an A-subclass (EphA1–A10) and a B-subclass (EphB1–B6).
Ephrins are divided into two subclasses. A-type ephrins are
tethered to the cell membrane by a glycosylphosphatidylinositol
anchor, and B-type ephrins have a transmembrane domain
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followed by a short cytoplasmic region containing a PDZ
domain-binding motif. Ephrin-As (ephrin-A1–A5) bind A-type
Ephs, and ephrin-Bs (ephrin-B1–B3) bind B-type Ephs.
Although the roles played by Ephs and ephrins in developing
tissues have been extensively characterized, many different
biological functions have also been attributed to these
receptor–ligand pairs in adult tissues, including the regulation
of tissue-border formation, axon guidance, cell migration and
vascular development.23–28 Most previous studies have focused
on the function of Eph-ephrin in the neuron and the
endothelial cell, but recently there have been some studies
investigating its role in the epithelial cell. Tanaka et al.29 have
reported that the overexpression of ephrin-B1 triggered a
change in the level of cell-cell adhesion in a study using
Madin–Darby canine kidney cells. There is also a report showing
that the Eph–ephrin-B family affects the cyto-architecture of
tubular epithelial cells and regulates their paracellular permea-
bility.30 All of these characteristics of the Eph–ephrin-B family
prompted us to analyze its expression in the podocyte.
In this study, we demonstrated that ephrin-B1 localizes at
the slit diaphragm. We observed that the expression of
ephrin-B1 was clearly reduced in rats injected with anti-
nephrin antibody (ANA). An RNA silencing study revealed
that ephrin-B1 plays a role in the proper localization of
CD2AP, one of the critical components of the slit diaphragm.
All of these results suggest that ephrin-B1 is one of the
essential constituents of the slit diaphragm complex.
RESULTS
Reverse transcription-polymerase chain reaction findings
of EphBs and ephrin-Bs, and cloning of rat homologues
of ephrin-B2 and EphB2
Reverse transcription-polymerase chain reaction (RT-PCR)
products for EphB1, EphB2, ephrin-B1, and ephrin-B2 were
detected in glomeruli and in cultured podocytes. The sizes of
the PCR products were the same as those in brain samples
(Figure 1a). Nucleotide sequencing analysis revealed open
reading frames of 1005 and 2961 nucleotides coding for a
predicted proteins of 334 and 986 amino acids for ephrin-B2
and EphB2, respectively. The identity of the ephrin-B2
amino-acid sequence of rat and mouse was 98.8%, and rat
and human was 97.3%. The identity of the EphB2 amino-
acid sequence of rat and human was 98.9% (Figure 1b, c).
The sequence data of rat ephrin-B2 and EphB2 we cloned are
available from GenBank under accession number DQ011670
and DQ011669, respectively.
Preparation of ANA-induced nephropathy, and mRNA
expression of EphBs and ephrin-Bs in ANA nephropathy
The average values of proteinuria in ANA nephropathy were
46.6 mg/day at 24 h, and 215.8 mg/day on day 5, respectively.
mRNA expression of EphB1 and ephrin-B2 did not decrease
at any time point examined. mRNA expression of EphB2 and
ephrin-B1 clearly decreased at 24 h of ANA nephropathy
(EphB2: 58.579.0%, ephrin-B1: 48.9711.5%), however
their expression recovered on day 5 (Figure 1d).
Ephrin-B1 is expressed in podocytes in normal adult rat
and in developing glomeruli
Positive bands of around 50 kDa were detected in rat
glomerular lysate using an antibody against the intracellular
site of ephrin-B1 produced in rabbit (Figure 2a, lane 1). The
sizes of the bands were compatible with findings reported
previously.29,31 The specific bands were not detected with
anti-ephrin-B1 antibody preabsorbed with the peptide used
for immunization (lane 3). No change was observed with
anti-ephrin-B1 antibody preabsorbed with the irrelevant
peptide (lane 4). IF staining of the anti-ephrin-B1 antibody
was detected along the glomerular capillary loop as
continuous pattern. The specific staining of ephrin-B1 along
capillary wall was detected at all the tufts in the glomeruli,
and the specific staining was detected in almost all glomeruli
in normal rat kidney sections (Figure 2b). Negative staining
was detected with normal rabbit serum (c). No positive
staining was detected with anti-ephrin-B1 antibody pre-
absorbed with the peptide used for immunization (d). The
preincubation with the ephrin-B1-specific peptide no. 1
clearly reduced the intensity of the staining (e), but the
preincubation with the same amount of the ephrin-B1-
specific peptide no. 2 (f) no. 3 (g) or an irrelevant peptide (h)
did not. The staining of the anti-ephrin-B1 antibody along
capillary loop was also observed in human kidney section
(Figure 2i, j). Dual-labeling IF study with glomerular cell
markers revealed that ephrin-B1 was detected with nephrin
and CD2AP. Ephrin-B1 staining of the antibody was apart
from the Thy1.1 and the anti-rat endothelial cell antigen
(RECA-1) staining (Figure 3a–l). Fifty kiloDalton bands with
Western blot analysis in glomerular lysate, and similar
pattern and sublocalization in glomeruli with IF study, were
observed with an antibody against the extracellular site
of ephrin-B1 produced in goat (data not shown). Immuno-
electron microscopic study revealed that gold particles for the
anti-ephrin-B1 antibody were mainly detected at the slit
diaphragm, although some gold particles were detected at the
basal surface of podocytes (Figure 3m–o).
Dual-labeling IF studies of ephrin-B1 with nephrin in
embryonic and infantile rat glomeruli showed that ephrin-B1
staining was still apart from nephrin staining at the early
capillary loop stage (Figure 3q), and that some portions of
ephrin-B1 staining colocalized with nephrin staining at the
late capillary loop stage (Figure 3r).
Ephrin-B1 is detected in the precipitate with ANA
The specific ephrin-B1 band and the CD2AP band were
detected in the immunoprecipitate with the ANA-coupled
gel. No band was detected in the precipitates of normal rabbit
serum. No band was detected with normal rabbit or goat
serum in the precipitates of the ANA (Figure 3t–y).
Ephrin-B1 expression decreased at the early phase of ANA
nephropathy
The staining of anti-ephrin-B1 antibody clearly decreased at
24 h of ANA nephropathy. The staining intensity recovered to
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the normal level on day 5 (Figure 4a–q). Alteration of nephrin
staining is not remarkable at 24 h, although the staining
clearly shifted to a discontinuous coarse granular pattern on
day 5. Western blot findings showed that the amount of
ephrin-B1 was decreased at 24 h of ANA nephropathy
(73.2714.8%) (Figure 4r).
CD2AP staining pattern altered in the cells treated with small
interference RNA for ephrin-B1
Ephrin-B1 staining was detected in the cultured podocytes
(Figure 5a–d). Ephrin-B1 was detected as radiating pattern
towards the tip end of processes in the cells treated with
control small interference RNA (siRNA). Dual-labeling IF
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Figure 1 | Reverse-transcription-(RT)-PCR findings of EphBs and ephrin-Bs, and cloning of rat homologues of ephrin-B2 and EphB2.
(a) RT-PCR findings of EphBs and ephrin-Bs. The sizes of the PCR products for EphB1, EphB2, ephrin-B1 and ephrin-B2 detected in glomeruli (G)
and in cultured podocytes (P) are the same as those in brain (B) samples. The PCR products corresponding to glyceraldehydes-3-phosphate
dehydrogenase (GAPDH) are shown at the bottom. (b) Comparison of the amino-acid sequences of rat, mouse, and human ephrin-B2. The dark
gray boxes indicate the conserved amino acids shared by rat, mouse, and human ephrin-B2. The gray boxes indicate the conserved amino
acids shared by ephrin-B2 from two of the three species. The identity of the amino-acid sequence of rat and mouse ephrin-B2 is 98.8%.
The identity of the amino-acid sequence of rat and human ephrin-B2 is 97.3%. The sequence data of rat ephrin-B2 we cloned are available
from GenBank under accession number DQ011670. (c) Comparison of the amino-acid sequences of rat and human EphB2. The gray boxes
indicate the conserved amino acids shared by rat and human EphB2. The identity of the amino-acid sequence of rat and human EphB2 is 98.9%.
The sequence data of rat EphB2 that we cloned are available from GenBank under accession number DQ011669. (d) Semi-quantitative
RT-PCR findings of EphB1, EphB2, ephrin-B1, and ephrin-B2 in ANA-induced nephropathy (ANA). The ratios of the densitometric signal to
that of GAPDH were analyzed; the data are shown as ratios relative to the normal findings and are expressed as means7s.d. of three
independent experiments. Representative agalose gel electrophoretic patterns from one of three experiments are shown at the bottom.
The mRNA expression of EphB2 and ephrin-B1 decreased at 24 h of ANA nephropathy (EphB2: 58.579.0%, ephrin-B1: 48.9711.5%).
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study revealed that CD2AP staining was similar pattern to
ephrin-B1 staining in the cells treated with control siRNA
(Figure 5i–k). mRNA expression of ephrin-B1 clearly
decreased in the material treated with siRNA for ephrin-B1
(29.7717.3%) (Figure 5e). IF study revealed that the
intensity of ephrin-B1 was clearly lowered in the cell treated
with ephrin-B1 siRNA (Figure 5f, g). Western blot analysis
also showed ephrin-B1 was decreased in the material treated
with siRNA for ephrin-B1 (66.977.6%) (Figure 5h). The
CD2AP signals were not detected at the processes, and those
were limitedly detected around the nuclei in the cells treated
with ephrin-B1 siRNA (Figure 5o). No significant difference
in F-actin staining was detected between the podocytes
treated with control siRNA and those treated with ephrin-B1
siRNA (Figure 5l, p).
DISCUSSION
The slit diaphragm of glomerular podocyte is a variant of
cell–cell junction, and is, recently, accepted to play a critical
role in regulating the barrier function of glomerular capillary
wall for retaining plasma proteins.1–3,12 However, the precise
molecular composition is not elucidated yet. Some recent
studies have demonstrated that the Eph–ephrin-B family
plays an important role in regulating the cell–cell perme-
ability in a variety of epithelial cells,29,30 although their roles
have been extensively characterized in the central nervous
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Figure 2 | Expression of ephrin-B1 in the glomeruli. (a) Western blot findings of ephrin-B1 in rat glomerular lysate. Positive bands of
around 50 kDa were detected with anti-ephrin-B1 antibody (rabbit) (lane 1). Bands were not detected with normal rabbit serum (lane 2).
The ephrin-B1-specific bands were not detected in the stripe stained with the antibody pre-incubated with its immunizing peptide (lane 3).
Positive bands were detected with the antibody preincubated with the same amount of irrelevant peptide (lane 4). (b–h) IF findings of
ephrin-B1 in rat glomeruli. (b) The staining of anti-ephrin-B1 antibody (rabbit) was detected along the glomerular capillary loop.
(c) Negative staining was detected with normal rabbit serum. (d) No positive staining was detected with anti-ephrin-B1 antibody preabsorbed
with the peptide used for immunization. The intensity of the staining with the antibody preincubated with the ephrin-B1-specific peptide no. 1
(e) was clearly lower than that with the antibody without pre-incubation. The preincubation with the ephrin-B1-specific peptide no. 2
(f), no. 3 (g), or an irrelevant peptide (h) did not reduced the intensity of the staining (original magnification  400). (i–j) IF findings of
ephrin-B1 in human glomeruli. (i) The staining of anti-ephrin-B1 antibody (rabbit) along the glomerular capillary loop was also observed in
human kidney section. (j) No positive staining was detected with normal rabbit serum (original magnification  400).
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system and the vascular system.22–28 In this study, first, we
analyzed whether the molecules of the Eph–ephrin-B are
expressed in podocyte. We detected the mRNA expression of
EphB1, EphB2, ephrin-B1, and ephrin-B2 in rat glomeruli
and in cultured podocytes (Figure 1a). Then, to investigate
whether these Eph–ephrin-B family molecules play a role in
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Figure 3 | Localization of ephrin-B1 in rat glomeruli. (a–l) Dual-labeling IF findings of ephrin-B1 (a–d, green) with glomerular cell markers
(i–l, red) in adult rat sections (e–h, merged image). Anti-rat endothelial cell antigen (RECA-1) antibody and anti-Thy1.1 antibody (mAb 1-22-3)
were used as an endothelial cell marker (i) and a mesangial cell marker (j), respectively. ANA (mAb 5-1-6) (k) and anti-CD2-associated protein
(CD2AP) antibody (goat) (l) were used as podocyte markers. The staining of anti-ephrin-B1 antibody (rabbit) was clearly apart from the RECA-1
(e) and Thy1.1 (f) staining. The ephrin-B1 staining colocalized with the nephrin staining (g), and with the CD2AP staining (h) (original
magnification,  400). (m–o) Immunoelectron microscopic findings. The gold particles for the anti-ephrin-B1 antibody (goat) were mainly
detected at the slit diaphragm (arrows) (m–o), although some gold particles were detected at the basal part of podocytes (m) (original
magnification: m, n:  39 380; o:  78 750). (p–s) Dual-labeling IF findings of anti-ephrin-B1antibody (green) with ANA (red) in embryonic
(p, q: embryonic day 20.5) and infantile (r, s) rat kidney sections. Ephrin-B1staining was clearly apart from nephrin staining at S-shaped body
stage (p) and at the early capillary loop stage (q). Some portions of ephrin-B1 staining colocalized with nephrin staining at the late capillary
loop stage (r) and at the developing stage (s) (arrows) (original magnification,  400). (t–y) Interaction of ephrin-B1 with nephrin.
Immunoprecipitation of anti-nephrin-antibody (rabbit) was performed with normal glomerular lysate solubilized by radioimmunoprecipitation
assay buffer (lanes 1, 3). Immunoprecipitation of preimmune normal rabbit serum (NRS) was carried out as a control (lanes 2, 4). Western
blot analysis with the precipitated materials was performed with ANA (rabbit) (t), anti-CD2AP antibody (rabbit) (u), anti-ephrin-B1 antibody
(goat) (v), preimmune normal rabbit serum (w, x) and normal goat serum (NGS) (y). The specific ephrin-B1 band (lane 1-v) and the CD2AP
band (lane 1-u) were detected in the immunoprecipitate of the ANA. No band was detected in the precipitates of normal rabbit serum
(lanes 2-t, 2-u, 2-v and lanes 4-w, 4-x, 4-y). No band was detected with normal rabbit or goat serum in the precipitates of the ANA
(lanes 3-w, 3-x, 3-f).
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maintaining the barrier function of the slit diaphragm, we
analyzed the mRNA expression in glomeruli with the slit
diaphragm dysfunction caused by ANA (monoclonal anti-
body (mAb) 5-1-6) injection. mAb 5-1-6 binds to extra-
cellular domain of nephrin and alters the molecular
composition of the slit diaphragm, thereby affecting the
glomerular permeability barrier, and causes massive protein-
uria.12,32 We found that mRNA of ephrin-B1 was signi-
ficantly decreased at 24 h after ANA injection, and no
alteration in mRNA expression of EphB1 or ephrin-B2 was
observed at any time points examined in ANA-induced
nephropathy. Thus, in this study, we focused on ephrin-B1,
and investigated the precise localization and function of
ephrin-B1 in the podocyte.
Ephrin-B1, originally named Lerk-2, is one of the
membrane-anchored protein ephrin-Bs,21,22 and its gene is
located at the centmeric region of the X chromosome.23,33
Ephrin-B1 has an extracellular domain, a single transmem-
brane domain, and a cytoplasmic tail.22,23 Ephrin-B1 staining
was clearly detected along the glomerular capillary wall by
immunohistochemistry. Dual-labeling IF study revealed that
the staining of ephrin-B1 was co-stained with that of
podocyte markers nephrin and CD2AP (Figure 3a–l). An
immunoelectron microscopy showed that immuno-gold
particles for ephrin-B1 were mainly localized at the slit
diaphragm (Figure 3m–o). In the interaction assay, ephrin-B1
was detected in the ANA-precipitate (Figure 3t–y). From
these observations, we concluded that ephrin-B1 is one of the
slit diaphragm-related molecules.
In this study, we also analyzed the expression of ephrin-B1
in the developing glomeruli. Ephrin-B1 staining was apart
from nephrin staining at the S-shaped body stage and at the
early capillary loop stage. Colocalization of ephrin-B1 with
nephrin was first detected at the late capillary loop stage
(Figure 3p–s), when the interdigitation of foot process and
the formation of the slit diaphragm began.3 In the current
study, we also demonstrated that not only mRNA expression,
but also the staining of ephrin-B1 in podocyte significantly
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Figure 4 | Ephrin-B1 expression in ANA-induced nephropathy. (a–q) IF findings of anti-ephrin-B1antibody in ANA nephropathy.
The staining of ephrin-B1 in normal, 24 h of ANA nephropathy (ANA 24 h) and 5 days of ANA nephropathy glomeruli (ANA 5 day) was evaluated
as described in Materials and Methods section. Representative glomeruli showing the score 0–4 were shown in the upper panel (a–e). The
graphs showing % of the glomeruli of each score to total number of the glomeruli are shown in the left panel (f–h). The data are shown
as mean7s.d. (n¼ 5 rats). Representative IF findings of anti-ephrin-B1 antibody (low (i–k) and high (l–n) magnification) were shown in the
middle panel (i–n). In normal rat glomeruli, the specific ephrin-B1 staining was detected along capillary loop in all tuft area, and more than
80% of glomeruli were classified as score 3 or 4 (i, l). The staining intensity of ephrin-B1 significantly decreased at 24 h (j, m), and it recovered to
normal level on day 5 (k, n). The representative nephrin stainings of each group were shown in the right panel (o–q). The alteration of
nephrin staining is not remarkable at 24 h (p), although the nephrin staining clearly shifted to a discontinuous coarse granular pattern on day 5
(q) (original magnification, i–k:  100; l–q:  400). (r) Western blot findings of anti-ephrin-B1 antibody (rabbit) in glomerular lysate solubilized
with SDS-PAGE sample buffer for rats at 24 h of ANA nephropathy. The ratios of the densitometric signal of ephrin-B1 to that of the
internal control actin were analyzed. The data are shown as ratios relative to the normal findings and are expressed as means7s.d. of
three independent experiments. Representative Western blotting patterns from one of three experiments are shown. The amount of
ephrin-B1 reduced at 24 h of ANA nephropathy (73.2714.8% to normal).
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cultured podocytes treated with control siRNA (i–l) or ephrin-B1 siRNA (m–p). Dual-labeling IF findings of anti-ephrin-B1 antibody (i, m) with
anti-CD2AP antibody (k, o) and merged imaged (j, n), and the single-labeling IF findings of F-actin staining (l, p) are shown. EphrinB-1
signals radiating from the perinuclear area towards the tip end of the processes were detected in the cells treated with control siRNA
(i, arrows). CD2AP signals were also detected at the processes in the cells treated with control siRNA (k, arrows). The intensity of
ephrin-B1 staining was reduced in the cells treated with ephrin-B1 siRNA (m). CD2AP signals at the processes were not detected in the
cells treated with ephrin-B1 siRNA. CD2AP signals were limitedly detected around the nuclei (o, arrows). No significant difference in
F-actin staining was detected between the cells treated with control siRNA and those treated with ephrin-B1 siRNA (l, p) (original
magnification,  200).
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decreased at the early phase of ANA-induced nephropathy.
We confirmed, with Western blot techniques, that the
amount of immunoreactive ephrin-B1 was reduced in
glomeruli at 24 h after ANA injection (Figure 4r). These
findings in the developmental and the proteinuric glomeruli
supported the idea that ephrin-B1 in podocyte is highly
associated with the slit diaphragm.
Finally, RNA silencing analysis for ephrin-B1 was per-
formed using cultured podocytes. In this study, we analyzed
the expression of CD2AP, an adaptor molecule enabling
nephrin to interact with the actin cytoskeleton,11,12,34 as a
representative of slit diaphragm molecules. In normal cultured
podocytes, ephrin-B1 was detected as signals radiating from
the perinuclear area toward the tip end of the processes of the
cell, and was co-stained with CD2AP. The radiating CD2AP
signals were hardly detected, and the condensed dot-like
signals around the nuclei were seen in the cells treated with
siRNA for ephrin-B1 (Figure 5i–p). This result indicates that
ephrin-B1 contributes to the proper localization of CD2AP in
the podocyte. It is conceivable that ephrin-B1 plays a role in
maintaining the slit diaphragm structure, probably through
the proper arrangement of CD2AP.
In this study, we showed that ephrin-B1 is expressed at the
slit diaphragm of glomerular podocyte. To our knowledge,
this is the first report on the expression of the molecules of
Eph-ephrin-B family in matured podocyte, although some
studies on the expressions of the molecules of Eph-ephrin-B
family in glomeruli have already been reported. Daniel and
co-workers reported that EphB1 (originally named ELK) and
ephrin-B1 (originally named Lerk-2) are observed as an
endothelial pattern along capillary loop in early-stage
glomeruli. They also reported that the EphB1 was observed
as a mesangial pattern in matured glomeruli, and that the
glomerular expression of ephrin-B1 was weak in matured
glomeruli.35 Takahashi and co-workers reported that ephrin-
B2 was identified in the presumptive podocyte in the
comma-shaped glomeruli, and that the staining in podocyte
disappeared in matured glomeruli. They also analyzed the
expression of EphB4, which they assumed as a counterpart of
ephrin-B2, and they described that distinctive EphB4 signals
were not detected in matured glomeruli.36 EphB receptors are
supposed to be a counterpart of ephrin-B1. EphB2 could be
the principal candidate for the counterpart of ephrin-B1 in
podocyte, because we observed that the kinetics of mRNA
expression for EphB2 in ANA-induced nephropathy was
similar to that of ephrin-B1 (Figure 1d). However, in this
study, we could not detect the protein level expression of
EphB2 in podocyte, in spite of several trials with the
commercial available antibodies and the antibodies prepared
by ourselves. Recently, Tanaka et al.29 reported that ephrin-B1
interacts with claudin, and the interaction induces the
phosphorylation of ephrin-B1. It is also reported that
ephrin-B1 phosphorylation is induced by stimulation with
platelet-derived growth factor.37 It has been reported that
cytoplasmic domain of ephrin-B1 has a signaling function
that is important for cell–cell adhesions, and fibroblast
growth factor signaling modulates this function.38 These
reports indicate that it is possible that ephrin-B1 at the
podocyte slit diaphragm functions independently with the
stimulation via Eph receptors. The function of the phos-
phorylated ephrin-B1 in podocyte remained unclear. Re-
cently, it has been observed that the phosphorylated nephrin
binds with the Nck adaptor proteins.19,20 It is reported that
the phosphorylated ephrin-B1 binds with Grb4 Src-homol-
ogy-2 domain but does not bind with Nck Src-homology-2
domain.39 These reports suggest that ephrin-B1 in podocyte
serves as another route for the signal transduction of the
extracellular signal to the cytoplasm molecules at the slit
diaphragm. The identification of a counterpart of ephrin-B1
and the clarification of the precise function of ephrin-B1 in
podocyte are awaited as future studies.
In conclusion, the localization of ephrin-B1 at the slit
diaphragm was detected by dual-labeling IF study and
immunoelectron microscopy. The expression of ephrin-B1
significantly decreased in podocytes with slit diaphragm
dysfunction. The staining pattern of CD2AP was altered in
the cultured podocytes treated with siRNA for ephrin-B1.
These results suggest that ephrin-B1 is one of the essential
components of the slit diaphragm.
MATERIALS AND METHODS
Animals
Specific pathogen-free 7 week-old female Wistar rats (Charles River
Japan, Atsugi, Japan) were used. All animal experiments were
conformed to the National Institutes of Health Guide for the Care
and Use of Laboratory Animals. Procedures for the present study
were approved by Animal Committee at Niigata University School
of Medicine, and all animals were treated according to the guidelines
for animal experimentation of Niigata University.
Antibodies
Rabbit anti-ephrin-B1 antibody (sc-1011), and its blocking peptide
(sc-1011P) that was used for immunization, were purchased from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Because the
sequence of the peptide used for immunization to produce the
antibody was not open to public, we intended to identify the site
recognized by the antibody with an absorption test with ephrin-B1-
specific peptides. Three ephrin-B1-specific peptides were designed
from the sequences of rat ephrin-B1 (GenBank accession number:
BC061744). The sequences of the peptides are as follows: peptide
no. 1, KLRKRHRKHTQQRAAA; peptide no. 2, GGSGTAGF; peptide
no. 3, TENNY. The peptides were purchased from GenScript
Corporation (Scotch Plains, NJ, USA). Goat anti-ephrin-B1 anti-
body was purchased from R&D systems Inc. (Minneapolis, MN,
USA). Mouse monoclonal antibodies to nephrin (mAb 5-1-6),40 to
Thy1.1 (mAb 1-22-3),41 and rabbit antibodies to nephrin42 and to
CD2AP43 were prepared as described previously. Goat anti-CD2AP
antibody (sc-8764) was purchased from Santa Cruz Biotechnology
Inc. The suppliers of other antibodies used in this study are
provided in Table 1.
RT-PCR
RT-PCR was performed basically according to the method described
previously.42,44,45 The sequences of the primers used for this study
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are provided in Table 2. For semi-quantitative RT-PCR, the band
intensity was determined by image analysis using Bio Doc-It System
and densitometry software, Lab Works 4.0 (UVP Inc., Upland, CA,
USA). The results were corrected for the amount of mRNA in the
sample by dividing by the intensity of the internal control
glyceraldehydes-3-phosphate dehydrogenase.
Western blot analysis
Western blot analysis was performed basically according to the
method previously reported.42–45 In brief, rat glomeruli or cultured
podocytes were solubilized with sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) sample buffer (2% SDS,
10% glycerol, 5% mercaptoethanol in 62.5 mmol/l Tris-HCl (pH
6.8])) with protease inhibitors. The solubilized material was
subjected to SDS-PAGE with 10 or 7.5% acrylamide gel and
transferred to a polyvinylidene fluoride transfer membrane (Pall
Corporation, Pensacola, FL, USA). After exposure to the primary
antibodies, alkaline phosphatase-conjugated secondly antibodies
were used. The reaction was developed with an alkaline phosphatase
chromogen kit (Biomedica, Foster City, CA, USA).
IF microscopy
An IF study was performed basically according to the method
described previously.42–45 Three-micrometer-thick frozen sections of
embryonic, infantile, adult rat kidneys, adult human kidney
sections, and the cultured cells on glass coverslips were fixed with
acetone for 1 min, and incubated with the primary antibodies. The
human kidney specimen was isolated from the normal part of
kidney that had been obtained from nephrectomy. Dual-labeling IF
for ephrin-B1 was carried out with RECA-1, Thy1.1, nephrin, and
CD2AP.
Immunoelectron microscopy
Rat kidneys were perfused with 0.5% paraformaldehyde fixative
buffered with 0.1 mol/l sodium phosphate buffer (PB), pH 7.4, and
the small pieces of the kidneys were immersed in the same fixative
for 30 min at 41C and then embedded in glycol methacrylate.
Ultrathin sections of the embedded tissues were collected on nickel
grids and incubated with 5% non-fat milk for 1 h and then with the
goat anti-ephrin-B1 antibody for 1 h. The sections were incubated
with gold (10 nm)-labeled anti-goat IgG (DAKO, Glostrup, Den-
mark) for 1 h. After immunostaining, they were fixed with 2.5%
glutaraldehyde buffered with 0.1 mol/l PB (pH 7.4). The sections
were then counterstained with 2% aqueous uranyl acetate and 2%
lead citrate for observation by electron microscope (H-600A,
Hitachi, Tokyo, Japan).
Cloning of rat ephrin-B2 and EphB2
To clone rat homologues of ephrin-B2 and EphB2, we employed
PCR with the primers designed from the human and mouse
sequences. PCR cloning was performed basically according to the
method described previously.42
Interaction assays
For immunoprecipitation, normal rat glomeruli were solubilized in
radioimmunoprecipitation assay buffer (0.1% SDS, 1% sodium
deoxycholate, 1% Triton X-100, 150 mmol/l NaCl, 10 mmol/l
ethylenediaminetetraacetic acid in 25 mmol/l Tris-Hcl (pH 7.2))
with protease inhibitors. ANA or pre-immune normal rabbit serum
was coupled with AminoLink Coupling Gel (PIERCE, Rockford, IL,
USA) according to the manufacturer’s protocol. Glomerular lysates
containing equal amounts of total protein were incubated with the
gel at 41C overnight, followed by centrifugation for 15 min at
15 000 r.p.m. The pellet was washed five times with PBS, then eluted
in SDS-PAGE sample buffer and boiled at 971C for 4 min. The
elution fractions were separated by SDS-PAGE followed by
immunoblotting with goat anti-ephrin-B1 antibody and rabbit
anti-CD2AP antibody.
Analyses with developing kidneys and cultured podocytes
Kidneys were removed from rats on 20.5 embryonic days and
from infant rats. Mouse cultured podocyte was kindly donated by
Dr P Mundel (Albert Einstein College of Medicine, Bronx, NY,
USA). Cultivation of conditionally immortalized mouse podocytes
was conducted as reported previously.46
Table 1 | Antibodies used in this study (information on other
antibodies is provided in the text)
Antibody Suppliers
Mouse monoclonal anti-rat
endothelial cell antigen (RECA-1)
antibody
Serotec Ltd, Oxford, JE, UK
Rabbit anti-rat actin antibody Sigma, St Louis, MO, USA
Rhodamine Phalloidin Cytoskeleton Inc., Denver, CO, USA
FITC-conjugated swine anti-rabbit
IgG
DAKO, Glostrup, Denmark
TRITC-conjugated goat anti-mouse
IgG1
Southern Biotechnology Associates,
Birmingham, AL, USA
TRITC-conjugated goat anti-mouse
IgG3
Southern Biotechnology Associates,
Birmingham, AL, USA
TRITC-conjugated donkey anti-goat
IgG
Protos Immunoresearch, San
Francisco, CA, USA
Alkaline phosphatase-conjugated
goat anti-rabbit IgG
Biosource International, Tago
Immunologicals, Camerillo, CA, USA
Alkaline phosphatase-conjugated
rabbit anti-goat IgG
Kirkegaard & Perry Laboratories Inc.,
Gaithersburg, MD, USA
FITC, fluorescein isothiocyanate; IgG, immunoglobulin G.
Table 2 | PCR primers used in this study
Molecule Size (bp) Sense primer sequence Antisense primer sequence Accession number
EphB1 524 GTGGCTACGATGAAAACCTG GAGCACATCTCTGGTGATTGC BC057301
EphB2 500 CCAGAATGGCGCCATCTTCCAGG CTGCAAGAGCTGTGGCTCAGG DQ011669
Ephrin-B1 560 GAGCAGGCAGCTGCTTGCAGC GCTCCGCAAGCGACATCGCAA BC061744
Ephrin-B2 624 CTGTGCCAGACCAGACCAAG CCACACTACGAGAAGGTCAGC DQ011670
GAPDH 515 CTCTACCCACGGCAAGTTCAA GGATGACCTTGCCCACAGC X02231
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PCR, polymerase chain reaction.
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Proteinuric model with slit diaphragm-specific injury
(ANA-induced nephropathy)
ANA nephropathy was induced in female Wistar rats by the
intravenous injection with 15 mg of monoclonal ANA (mAb 5-1-6).
Kidney materials of five rats each were removed just before and 24 h
and 5 days after the injection for IF and PCR analyses. A portion of
right kidney was used for IF study. The IF staining of ephrin-B1 was
semiquantified basically according to the method described by
Macconi et al.47 (score 0, completely absent; score 1, signal covering
0–25 of the glomerular tuft area; score 2, 25–50%; score 3, 50–75%;
and score 4, 75–100%). A score was assigned to each glomerulus,
and more than 100 glomeruli in four non-sequential sections of each
rat were analyzed in a blind manner. Glomerular RNA was prepared
from the remaining kidney tissues pooled from five rats. Other three
rats were injected with ANA, and the kidney materials were removed
at 24 h after injection. The kidneys were also removed from three
age-matched normal control rats. Glomeruli were isolated with the
kidney pooled from three rats of each group, solubilized with SDS-
PAGE sample buffer, and used for Western blot analysis.
RNA silencing analysis
The siRNA sequences targeting mouse ephrin-B1 (GenBank
accession number: NM_010110) were synthesized by QIAGEN Inc.
(Valencia, CA, USA). The sense and antisense strands of siRNA were
used. The sequence of the sense strand was 50-AUAACGAUCUU-
CAUAGUGCdGdG-30, corresponding to regions in the exon 3 of
ephrin-B1. BLAST searches of selected sequences revealed no
significant homology to other murine genes. Negative control
siRNA of nonspecific nucleotide sequence were purchased from
QIAGEN Inc. Before transfection, podocytes were cultured to a
density of 70–80% at 371C and then they were transfected with the
siRNA using HiPerFect Transfection Reagent (QIAGEN Inc.),
according to the manufacturer’s instructions. Cells were harvested
for 48 h after siRNA treatment for RT-PCR, IF, and Western blot
analyses.
ACKNOWLEDGMENTS
The authors wish to thank Ms Mutsumi Kayaba for excellent technical
assistance, Mr Masaaki Nameta for indispensable help in the
ultrastructural techniques, and Ms Matsu Honma for kind supports.
This work was supported by Grant-Aids for Scientific Research (B)
(14370317 to HK, and 15390268 to FS) and (C) (18590886 to HK) from
Ministry of Education, Culture, Sports, Science and Technology of
Japan.
REFERENCES
1. Rodewald R, Karnovsky MJ. Porous substructure of the glomerular slit
diaphragm in the rat and mouse. J Cell Biol 1974; 60: 423–433.
2. Kriz W, Kobayashi N, Elger M. New aspects of podocyte structure,
function, and pathology. Clin Exper Nephrol 1998; 2: 85–99.
3. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte.
Physiol Rev 2003; 83: 253–307.
4. Wernerson A, Duner F, Pettersson E et al. Altered ultrastructural
distribution of nephrin in minimal change nephritic syndrome. Nephrol
Dial Transplant 2003; 18: 70–76.
5. Doublier S, Ruotsalainen V, Salvidio G et al. Nephrin redistribution on
podocytes is a potential mechanism for proteinuria in patients with
primary acquired nephritic syndrome. Am J Pathol 2001; 158: 1723–1731.
6. Kriz W, Elger M, Mundel P et al. Structure-stabilizing forces in the
glomerular tuft. J Am Soc Nephrol 1995; 5: 1731–1739.
7. Kriz W, Hackenthal E, Nobiling R et al. A role for podocyted to counteract
capillary wall distension. Kidney Int 1994; 45: 369–376.
8. Kestila M, Lenkkeri U, Mannikko M et al. Positionally cloned gene for a
novel glomerular protein-nephrin-is mutated in congenital nephrotic
syndrome. Mol Cell 1998; 1: 575–582.
9. Donoviel DB, Freed DD, Vogel H et al. Proteinuria and perinatal lethality in
mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell
Biol 2001; 21: 4829–4836.
10. Yaoita E, Kurihara H, Yoshida Y et al. Role of Fat1 in cell–cell contact
formation of podocytes in puromycin aminonucleoside nephrosis and
neonatal kidney. Kidney Int 2005; 68: 542–551.
11. Yuan H, Takeuchi E, Salant DJ. Podocyte slit-diaphragm protein nephrin is
linked to the actin cytoskeleton. Am J Physiol Renal Physiol 2002; 282:
F585–F591.
12. Kawachi H, Miyauchi N, Suzuki K et al. Role of podocyte slit diaphragm as
a filtration barrier. Nephrology 2006; 11: 274–281.
13. Lehtonen S, Lehtonen E, Kudlicka K et al. Nephrin forms a complex
with adherens junction proteins and CASK in podocytes and in
Madin–Darby canine kidney cells expressing nephrin. Am J Pathol 2004;
165: 923–936.
14. Lehtonen S, Ryan JJ, Kudlicka K et al. Cell junction-associated proteins
IQGAP1, MAGI-2, CASK, spectrins, and alpha-actin are components of the
nephrin multiprotein complex. Proc Natl Acad Sci USA 2005; 102:
9814–9819.
15. Huber TB, Kottgen M, Schilling B et al. Interaction with podocin facilitates
nephrin signaling. J Biol Chem 2001; 276: 41543–41546.
16. Huber TB, Hartleben B, Kim J et al. Nephrin and CD2AP associate with
phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling.
Mol Cell Biol 2003; 23: 4917–4928.
17. Benzing T. Signaling at the slit diaphragm. J Am Soc Nephrol 2004; 15:
1382–1391.
18. Verma R, Wharram B, Kovari I et al. Fyn binds to and phosphorylates the
kidney slit diaphragm component Nephrin. J Biol Chem 2003; 278:
20716–20723.
19. Verma R, Kovari I, Soofi A et al. Nephrin ectodomain engagement results
in Src kinase activation, nephrin phosphorylation, Nck recruitment, and
actin polymerization. J Clin Invest 2006; 116: 1346–1359.
20. Jones N, Blasutig IM, Eremina V et al. Nck adaptor proteins link nephrin
to the actin cytoskeleton of kidney podocytes. Nature 2006; 440:
818–823.
21. Eph Nomenclature Committee. Unified nomenclature for Eph family
receptors and their ligands, the ephrins. Cell 1997; 90: 403–404.
22. Kullander K, Klein R. Mechanisms and functions of Eph and ephrin
signaling. Nat Rev Mol Cell Biol 2002; 3: 475–486.
23. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour.
Nat Rev Mol Cell Biol 2005; 6: 462–475.
24. Martinez A, Soriano E. Functions of ephrin/Eph interactions in the
development of the nervous system: emphasis on the hippocampal
system. Brain Res Rev 2005; 49: 211–226.
25. Poliakov A, Cotrina M, Wilkinson DG. Diverse roles of eph receptors and
ephrins in the regulation of cell migration and tissue assembly. Dev Cell
2004; 7: 465–480.
26. Klein R, Palmer A. Multiple roles of ephrins in morphogenesis, neuronal
networking, and brain function. Genes Dev 2003; 17: 1429–1450.
27. Yamaguchi Y, Pasquale EB. Eph receptors in the adult brain. Curr Opin
Neurobiol 2004; 14: 288–296.
28. Cheng N, Brantley DM, Chen J. The ephrins and Eph receptors in
angiogenesis. Cytokine Growth Factor Rev 2002; 13: 75–85.
29. Tanaka M, Kamata R, Sakai R. Phosphorylation of ephrin-B1 via the
interaction with claudin following cell–cell contact formation. EMBO
J 2005; 24: 3700–3711.
30. Ogawa K, Wada H, Okada N et al. EphB2 and ephrin-B1 expressed in the
adult kidney regulate the cytoarchitecture of medullary tubule cells
through Rho family GTPases. J Cell Sci 2006; 119: 559–570.
31. Kalo MS, Yu HH, Pasquale EB. In vivo tyrosine phosphorylation sites of
activated ephrinB1 and EphB2 from neural tissue. J Biol Chem 2001; 276:
38940–38948.
32. Kawachi H, Kurihara H, Topham PS et al. Slit diaphragm-reactive
nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes.
Am J Physiol 1997; 273: F984–F993.
33. Fletcher FA, Renshaw B, Hollingsworth T et al. Genomic organization and
chromosomal localization of mouse Eplg2, a gene encoding a binding
protein for the receptor tyrosine kinase elk. Genomics 1994; 24: 127–132.
34. Shih NY, Li J, Karpitskii V et al. Congenital nephrotic syndrome in mice
lacking CD2-associated protein. Science 1999; 286: 312–331.
35. Daniel TO, Stein E, Cerretti DP et al. ELK and LERK-2 in developing kidney
and microvascular endothelial assembly. Kidney Int Suppl 1996; 57:
S73–S81.
36. Takahashi T, Takahashi K, Gerety S et al. Temporally compartmentalized
expression of ephrin-B2 during renal glomerular development. J Am Soc
Nephrol 2001; 12: 2673–2682.
Kidney International (2007) 72, 954–964 963
T Hashimoto et al.: Ephrin-B1 in slit diaphragm of glomerular podocyte o r i g i n a l a r t i c l e
37. Bruckner K, Pasquale EB, Klein R. Tyrosine phosphorylation of
transmembrane ligands for Eph receptors. Science 1997; 275: 1640–1643.
38. Chong LD, Park EK, Latimer E et al. Fibroblast growth factor
receptor-mediated rescue of x-ephrin B1-induced cell dissociation in
Xenopus embryos. Mol Cell Biol 2000; 20: 724–734.
39. Cowan CA, Henkemeyer M. The SH2/SH3 adaptor Grb4 transduces
B-ephrin reverse signals. Nature 2001; 413: 174–179.
40. Orikasa M, Matsui K, Oite T, Shimizu F. Massive proteinuria induced in rats
by a single intravenous injection of a monoclonal antibody. J Immunol
1988; 141: 807–814.
41. Kawachi H, Orikasa M, Matsui K et al. Epitope-specific induction of
mesangial lesions with proteinuria by a MoAb against mesangial cell
surface antigen. Clin Exp Immunol 1992; 88: 399–404.
42. Kawachi H, Koike H, Kurihara H et al. Cloning of rat nephrin: expression in
developing glomeruli and in proteinuric states. Kidney Int 2000; 57:
1949–1961.
43. Nakatsue T, Koike H, Han GD et al. Nephrin and podocin dissociate
at the onset of proteinuria in experimental membranous nephropathy.
Kidney Int 2005; 67: 2239–2253.
44. Kawachi H, Koike H, Kurihara H et al. Cloning of rat homologue of
podocin: expression in proteinuric states and in developing glomeruli.
J Am Soc Nephrol 2003; 14: 46–56.
45. Miyauchi N, Saito A, Karasawa T et al. Synaptic vesicle protein 2B is
expressed in podocyte, and its expression is altered in proteinuric
glomeruli. J Am Soc Nephrol 2006; 17: 2748–2759.
46. Mundel P, Reiser J, Zuniga Mejia Borja A et al. Rearrangements of the
cytoskeleton and cell contacts induce process formation during
differentiation of conditionally immortalized mouse podocyte cell lines.
Exp Cell Res 1997; 236: 248–258.
47. Macconi D, Bonomelli M, Benigni A et al. Pathophysiologic implications of
reduced podocyte number in a rat model of progressive glomerular
injury. Am J Pathol 2006; 168: 42–54.
964 Kidney International (2007) 72, 954–964
o r i g i n a l a r t i c l e T Hashimoto et al.: Ephrin-B1 in slit diaphragm of glomerular podocyte
